This table provides a summary of studies on the duration of protection of COVID-19 vaccines. This table is updated weekly.

The VIEW-hub report displays data and figures on the introduction, use, and coverage status of typhoid conjugate, human papillomavirus, pneumococcal, rotavirus, Haemophilus influenzae type b, and inactivated polio vaccines both globally and in the

This document outlines the methods used in the COVID-19 vaccines neutralization and cellular immunity studies review. 

In partnership with the Asian Development Bank, IVAC developed factsheets summarizing key measures for COVID-19 vaccines such as effectiveness and protection against severe disease.

The VIEW-hub report displays data and figures on the introduction, use, and coverage status of typhoid conjugate, human papillomavirus, pneumococcal, rotavirus, Haemophilus influenzae type b, and inactivated polio vaccines both globally and in the

This table summarizes vaccine impact results for COVID-19 studies conducted globally. This table is updated weekly.

These forest plots summarize available COVID-19 vaccine effectiveness against Delta and Omicron variants by vaccine, disease outcome, and study population.

The VIEW-hub report displays data and figures on the introduction, use, and coverage status of typhoid conjugate, human papillomavirus, pneumococcal, rotavirus, Haemophilus influenzae type b, and inactivated polio vaccines both globally and in the

This file contains a list of neutralization studies identified from an ongoing systematic review of literature evaluating the impact of SARS-CoV 2 variants of concern on COVID-19 vaccine performance. 

These forest plots summarize available COVID-19 vaccine effectiveness data by vaccine and variant of concern.